Company
Board Member
2023-09-20–present
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
The company reported in an 8-K filed April 7, 2026 that Nanaz Mohtashami resigned as director, effective April 7, 2026. The company reported in an 8-K filed September 22, 2023 that Nanaz Mohtashami was appointed director, effective September 20, 2023.
“Pursuant to the Merger Agreement, at the Effective Time, the following persons, who were directors of the Company immediately prior to the completion of the Merger, voluntarily resigned from the board of directors of the Company (the "Board") and from any and all committees of the Board on which they served: Stephen P. MacMillan, Charles J. Dockendorff, Ludwig N. Hantson, Martin Madaus, Wayde McMillan, Nanaz Mohtashami, Christiana Stamoulis, Stacey D. Stewart and Amy M. Wendell.”
“On September 20, 2023, the Board of Directors (the "Board") of Hologic, Inc. (the "Company"), upon the recommendation of the Company's Nominating and Corporate Governance Committee, increased the size of the Board from nine to ten directors and appointed Nanaz Mohtashami as a director of the Company, effective September 20, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
Board Member
SEC 8-K
2023-09-20–present
Organization not stated
Board Member
SEC 8-K
2023-09-20–2026-04-07
Recorded roles and call appearances connecting this person to public companies.
Company
Board Member
2023-09-20–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.